Comparing the current results to its competitors, Walgreens Boots Alliance Inc reported Revenue increase in the 3 quarter 2025 by 7.25 % year on year. The revenue growth was below Walgreens Boots Alliance Inc 's competitors' average revenue growth of 11.87 %, achieved in the same quarter.
Walgreens Boots Alliance Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 9.83 %
Walgreens Boots Alliance Inc 's Comment on Competition and Industry Peers
The competitive landscape includes brand name drugs competing with generic versions, which significantly affects retail pharmacy gross profit during the initial months of generic conversion. The timing and number of these conversions vary annually and are difficult to predict, impacting sales and profits. Additionally, the U.S. specialty prescription business is expanding, producing higher sales per prescription but with lower gross margins compared to generic drugs.
July 12, 2025
In a move that signals a significant shift in the landscape of retail pharmacy, Walgreens Boots Alliance, Inc. (Nasdaq: WBA) shareholders have decisively approved the company s acquisition by entities affiliated with Sycamore Partners Management, L.P. At the special shareholders meeting, an overwhelming 96% of votes cast were in favor of the transaction, illuminating a clear path forward for a merger that promises to reshape the future of the company.The enthusiasm among shareholders underscores a collective confidence in Sycamore Partners strategic direction for Walgreens. As one of the premiere private equity firms, Sycamore Partners has built a formidable reputation by specializing in the consumer, retai...
March 28, 2025
Balancing the Scales: Walgreens Boots Alliance Faces Legal Battles and Market Challenges In a complex weave of litigation and market dynamics, Walgreens Boots Alliance, Inc. (WBA) finds itself at a crucial crossroads. As investors scramble to meet a pivotal legal deadline, the company grapples with revenue growth challenges that have led to a dip in market share. Understanding the intricacies of these developments and their potential impact on the company is key for stakeholders as the March 31, 2025, deadline looms on the horizon. Navigating Legal Hurdles: The Securities Class Action Suit At the heart of WBA s current predicament is an ongoing securities class-action lawsuit. The Rosen Law Firm, a global le...
March 3, 2025
In a troubling turn of events for shareholders, Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is now at the center of a class action lawsuit, raising questions about the company s financial health and market positioning. Announced on March 3, 2025, The Gross Law Firm has issued a notice inviting shareholders who believe they have incurred losses to join the class action suit aimed at seeking recovery. Financial Performance HighlightWalgreens Boots Alliance s recent quarterly results paint a mixed picture. For the fourth quarter of 2024, the company reported a revenue increase of 7.49% year-on-year, showcasing its ability to grow even amidst challenging market conditions. However, when juxtaposed with its comp...
Publicly Traded Peers of Walgreens Boots Alliance Inc
China Jo Jo Drugstores Holdings Inc Share Performance
0.00%
This Quarter
China Jo Jo Drugstores Holdings Inc
Profile
China Jo Jo Drugstores Holdings Inc. is a Chinese company that operates retail drugstores in the country. Their business model focuses on providing pharmaceutical products and healthcare services directly to customers through their physical stores. They aim to meet the growing demand for accessible and affordable medical care in China by offering a wide range of products and services, including prescription and over-the-counter drugs, medical devices, and traditional Chinese medicines.
Allscripts Healthcare Solutions Inc is a leading provider of healthcare information technology solutions. They offer a broad range of software, hardware, and services to help healthcare organizations streamline their workflows, enhance patient care, and improve clinical and financial outcomes. By focusing on technological innovation and customer-centric approach, Allscripts aims to empower healthcare professionals and transform the delivery of care.
Optimizerx Corp's business model revolves around providing a platform that connects pharmaceutical companies, healthcare providers, and patients. The company aims to enhance medication adherence and patient engagement by offering digital tools, including electronic vouchers, co-pay savings, and messaging services.
Rite Aid Corp operates as a retail pharmacy chain, offering a range of healthcare products and services. Their business model revolves around providing prescription medications, over-the-counter drugs, personal care items, and general merchandise to customers through their physical store locations. Rite Aid also offers pharmacy benefit management services and operates walk-in clinics for basic medical services.
Sharing Services Global Corporation Share Performance
0.00%
Over The Past 5 Days
Sharing Services Global Corporation
Profile
Sharing Services Global Corporation operates as a direct-selling company that offers a variety of health, wellness, and lifestyle products through its independent sales force.
Sources:
Walgreens Boots Alliance Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Walgreens Boots Alliance Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
